vs
Palladyne AI Corp.（PDYN）与Prime Medicine, Inc.（PRME）财务数据对比。点击上方公司名可切换其他公司
Palladyne AI Corp.的季度营收约是Prime Medicine, Inc.的2.0倍（$1.7M vs $838.0K），Palladyne AI Corp.净利率更高（-89.9% vs -5498.7%，领先5408.8%），Palladyne AI Corp.同比增速更快（118.3% vs -61.6%），Palladyne AI Corp.自由现金流更多（$-8.7M vs $-37.5M）
Palladyne AI Corp是一家美国企业，其前身1983年成立时名为萨科斯研究公司，企业长期以来以机器人开发为核心业务。2023年，公司调整业务方向，专注开发适用于机器人场景的人工智能软件，终止了硬件业务，并于2024年3月正式更名为现用名。
Prime Medicine, Inc.是一家总部位于美国马萨诸塞州剑桥的生物科技企业，核心业务是依托先导编辑技术开发新型基因治疗方案，致力于为遗传病等相关疾病探索创新治疗手段，推动前沿基因编辑技术的临床转化与应用。
PDYN vs PRME — 直观对比
营收规模更大
PDYN
是对方的2.0倍
$838.0K
营收增速更快
PDYN
高出179.9%
-61.6%
净利率更高
PDYN
高出5408.8%
-5498.7%
自由现金流更多
PDYN
多$28.8M
$-37.5M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7M | $838.0K |
| 净利润 | $-1.5M | $-46.1M |
| 毛利率 | 15.6% | — |
| 营业利润率 | -560.7% | -5800.5% |
| 净利率 | -89.9% | -5498.7% |
| 营收同比 | 118.3% | -61.6% |
| 净利润同比 | 97.2% | -9.0% |
| 每股收益（稀释后） | $-0.02 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PDYNPRME
| Q4 25 | $1.7M | $838.0K | ||
| Q3 25 | $860.0K | $1.2M | ||
| Q2 25 | $1.0M | $1.1M | ||
| Q1 25 | $1.7M | $1.5M | ||
| Q4 24 | $761.0K | $2.2M | ||
| Q3 24 | $871.0K | — | ||
| Q2 24 | $2.7M | $0 | ||
| Q1 24 | $3.4M | $591.0K |
净利润PDYNPRME
| Q4 25 | $-1.5M | $-46.1M | ||
| Q3 25 | $-3.7M | $-50.6M | ||
| Q2 25 | $-7.5M | $-52.6M | ||
| Q1 25 | $22.8M | $-51.9M | ||
| Q4 24 | — | $-42.3M | ||
| Q3 24 | $-7.1M | — | ||
| Q2 24 | $-5.3M | $-55.3M | ||
| Q1 24 | $-7.2M | $-45.8M |
毛利率PDYNPRME
| Q4 25 | 15.6% | — | ||
| Q3 25 | 46.4% | — | ||
| Q2 25 | 53.3% | — | ||
| Q1 25 | 79.4% | — | ||
| Q4 24 | 27.2% | — | ||
| Q3 24 | 45.0% | — | ||
| Q2 24 | 79.0% | — | ||
| Q1 24 | 45.2% | — |
营业利润率PDYNPRME
| Q4 25 | -560.7% | -5800.5% | ||
| Q3 25 | -937.8% | -4406.0% | ||
| Q2 25 | -797.4% | -4787.2% | ||
| Q1 25 | -405.3% | -3603.3% | ||
| Q4 24 | — | -2025.7% | ||
| Q3 24 | -838.0% | — | ||
| Q2 24 | -213.3% | — | ||
| Q1 24 | -213.7% | -8179.5% |
净利率PDYNPRME
| Q4 25 | -89.9% | -5498.7% | ||
| Q3 25 | -434.9% | -4129.1% | ||
| Q2 25 | -737.6% | -4716.7% | ||
| Q1 25 | 1330.9% | -3568.8% | ||
| Q4 24 | — | -1936.6% | ||
| Q3 24 | -814.7% | — | ||
| Q2 24 | -196.2% | — | ||
| Q1 24 | -210.1% | -7743.0% |
每股收益（稀释后）PDYNPRME
| Q4 25 | $-0.02 | $-0.22 | ||
| Q3 25 | $-0.09 | $-0.32 | ||
| Q2 25 | $-0.20 | $-0.41 | ||
| Q1 25 | $0.55 | $-0.40 | ||
| Q4 24 | — | $-0.31 | ||
| Q3 24 | $-0.27 | — | ||
| Q2 24 | $-0.20 | $-0.46 | ||
| Q1 24 | $-0.28 | $-0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.1M | $63.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $74.7M | $120.9M |
| 总资产 | $95.7M | $342.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PDYNPRME
| Q4 25 | $47.1M | $63.0M | ||
| Q3 25 | $57.1M | $71.4M | ||
| Q2 25 | $62.7M | $53.8M | ||
| Q1 25 | $46.6M | $91.9M | ||
| Q4 24 | $40.1M | $182.5M | ||
| Q3 24 | $21.3M | — | ||
| Q2 24 | $25.8M | $55.6M | ||
| Q1 24 | $31.8M | $94.2M |
股东权益PDYNPRME
| Q4 25 | $74.7M | $120.9M | ||
| Q3 25 | $51.8M | $161.8M | ||
| Q2 25 | $53.8M | $60.9M | ||
| Q1 25 | $28.3M | $106.9M | ||
| Q4 24 | $-9.5M | $153.1M | ||
| Q3 24 | $23.4M | — | ||
| Q2 24 | $29.8M | $196.6M | ||
| Q1 24 | $34.2M | $243.8M |
总资产PDYNPRME
| Q4 25 | $95.7M | $342.7M | ||
| Q3 25 | $72.9M | $385.0M | ||
| Q2 25 | $78.3M | $279.0M | ||
| Q1 25 | $63.3M | $328.2M | ||
| Q4 24 | $56.3M | $297.5M | ||
| Q3 24 | $38.7M | — | ||
| Q2 24 | $45.1M | $259.7M | ||
| Q1 24 | $50.4M | $311.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.5M | $-37.3M |
| 自由现金流经营现金流 - 资本支出 | $-8.7M | $-37.5M |
| 自由现金流率自由现金流/营收 | -526.2% | -4480.4% |
| 资本支出强度资本支出/营收 | 14.2% | 34.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-167.1M |
8季度趋势，按日历期对齐
经营现金流PDYNPRME
| Q4 25 | $-8.5M | $-37.3M | ||
| Q3 25 | $-6.3M | $-35.0M | ||
| Q2 25 | $-5.3M | $-41.4M | ||
| Q1 25 | $-7.5M | $-48.9M | ||
| Q4 24 | $-22.6M | $16.2M | ||
| Q3 24 | $-4.5M | — | ||
| Q2 24 | $-5.8M | $-45.5M | ||
| Q1 24 | $-7.2M | $-67.7M |
自由现金流PDYNPRME
| Q4 25 | $-8.7M | $-37.5M | ||
| Q3 25 | $-6.7M | $-35.3M | ||
| Q2 25 | — | $-43.0M | ||
| Q1 25 | $-7.6M | $-51.3M | ||
| Q4 24 | $-22.9M | $14.5M | ||
| Q3 24 | $-4.5M | — | ||
| Q2 24 | $-5.9M | $-47.4M | ||
| Q1 24 | $-7.3M | $-70.0M |
自由现金流率PDYNPRME
| Q4 25 | -526.2% | -4480.4% | ||
| Q3 25 | -776.0% | -2880.5% | ||
| Q2 25 | — | -3855.1% | ||
| Q1 25 | -445.0% | -3526.8% | ||
| Q4 24 | -3008.1% | 662.1% | ||
| Q3 24 | -517.8% | — | ||
| Q2 24 | -218.9% | — | ||
| Q1 24 | -212.1% | -11849.6% |
资本支出强度PDYNPRME
| Q4 25 | 14.2% | 34.6% | ||
| Q3 25 | 44.7% | 20.2% | ||
| Q2 25 | 0.0% | 141.0% | ||
| Q1 25 | 5.4% | 166.6% | ||
| Q4 24 | 34.8% | 82.0% | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 1.8% | 393.2% |
现金转化率PDYNPRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
